title: Cryofibrinogenaemia: a study of 49 patients.
abstract: The purpose of this study was to characterize the clinical features and components of 30 patients with isolated cryofibrinogen (CF) versus those of 19 patients with combined CF and cryoglobulins (CG). Secondary forms of cryofibrinogenaemia associated with collagen disorders, infectious or malignant diseases, were significantly more frequent in patients with combined CF and CG than those with isolated CF (79 versus 47%, P = 0.02). Both groups of CF patients presented predominantly cutaneous symptoms (77% in isolated CF; 58% in combined CF + CG), and less frequently venous and/or arterial thrombosis (13% in isolated CF; 3% in combined CF + CG). Patients with idiopathic forms of CF, and particularly those without CG, suffered essentially from recurrent painful skin ulcers, mainly triggered by cold exposure. Patients with isolated CF had higher mean plasma concentrations of CF than those with combined CF + CG (1. 61 +/- 1.26 versus 0.82 +/- 1.18 g/l, respectively; P = 0.004), but there was no correlation between the CF plasma level and either the severity of symptoms or the sensitivity to cold. In patients with isolated CF, fibronectin was suggested (by precipitation analysis) to be a major component of the cryoprecipitate, whereas immunoglobulins were rarely present (in only three out of 30 patients). By contrast, in the majority of patients (78%) with combined CF and CG, the CF consisted mainly of immunoglobulins of the same class as those characterizing the associated CG. Analysis of the CG precipitate revealed the presence of fibronectin but not fibrinogen, alpha1-antitrypsin and alpha2-macroglobulin. In conclusion, isolated and combined cryofibrinogenaemia are associated with different clinical signs requiring different clinical management, but there is no evidence as yet for a causal role of the cryoprecipitates in the differences observed.
authors.affiliation: Department of Internal Medicine II, University Hospital Pitié-Salpêtrière, Paris, France.
authors.forename: H
authors.initials: H
authors.lastname: Blain
authors.forename: P
authors.initials: P
authors.lastname: Cacoub
authors.forename: L
authors.initials: L
authors.lastname: Musset
authors.forename: N
authors.initials: N
authors.lastname: Costedoat-Chalumeau
authors.forename: C
authors.initials: C
authors.lastname: Silberstein
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
authors.forename: P
authors.initials: P
authors.lastname: Godeau
authors.forename: C
authors.initials: C
authors.lastname: Frances
authors.forename: J C
authors.initials: JC
authors.lastname: Piette
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D003449:Cryoglobulinemia / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D003450:Cryoglobulins / Q000032:analysis*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D015241:Fibrinogens, Abnormal / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D003450:Cryoglobulins; D015241:Fibrinogens, Abnormal; C041874:cryofibrinogen; D005340:Fibrinogen